The CSNK1G3 Knockout Raji Polyclonal Cells represent a heterogeneous pool of Raji B lymphocytes in which the CSNK1G3 gene has been disrupted using CRISPR/Cas9 genome editing. This polyclonal knockout population provides a genetically defined loss-of-function model that allows researchers to investigate the functional contributions of casein kinase 1 gamma 3 (CSNK1G3) in a human lymphoblastoid background. Unlike monoclonal knockout lines, the polyclonal format maintains a degree of cellular heterogeneity, which can be advantageous for studies that aim to capture population-level signaling dynamics without clonal artifacts. The cells are supplied as a ready-to-use product, facilitating direct integration into a wide array of biochemical, cell-based, and pharmacological assays.
The Raji cell line is a well-established human B lymphocyte model derived from a Burkitt??s lymphoma patient. It is extensively utilized in immunology and cancer research, particularly in studies of B cell receptor signaling, Epstein-Barr virus (EBV) latency, and lymphoma biology. Raji cells exhibit a lymphoblastoid phenotype and carry latent EBV genomes, making them a valuable system for examining viral-host interactions and B cell transformation. Their robust proliferation and ease of culture further enhance their utility for high-throughput screening and mechanistic investigations. In the context of CSNK1G3 knockout, the Raji background provides a disease-relevant cellular environment that is especially suitable for exploring kinase functions in lymphoma and immune cell signaling.
CSNK1G3 encodes a serine/threonine-protein kinase that operates as a key regulator in multiple signaling cascades, with prominent roles in the Wnt/??-catenin pathway and circadian rhythm control. In canonical Wnt signaling, CSNK1G3 phosphorylates the LRP6 co-receptor and Dishevelled (DVL) proteins, promoting the assembly of the Wnt signalosome and subsequent stabilization of ??-catenin. This leads to the activation of TCF/LEF transcription factors, which drive the expression of Wnt target genes involved in cellular proliferation and differentiation. Additionally, CSNK1G3 interacts with AXIN and GSK3?? within the ??-catenin destruction complex, further modulating pathway flux. Beyond Wnt signaling, CSNK1G3 phosphorylates PER proteins in the circadian clock, influencing their degradation and nuclear translocation, thereby contributing to the maintenance of circadian periodicity. Its activity is regulated by upstream factors including Wnt ligands and CK1 activating cofactors, and it functions downstream of Frizzled receptor activation.
The disruption of CSNK1G3 in the Raji lymphoma cell line creates a powerful tool for dissecting the kinase??s role in B cell malignancies. Given the frequent dysregulation of Wnt signaling in various cancers, including lymphomas, this knockout model enables the examination of CSNK1G3-dependent contributions to oncogenic proliferation and survival. In particular, Raji cells provide a context in which the interplay between Wnt pathway activation, EBV latency, and B cell receptor signaling can be probed. By eliminating CSNK1G3 function, researchers can assess changes in ??-catenin transcriptional output, cell cycle progression, and sensitivity to chemotherapeutic agents or kinase inhibitors. This model thus facilitates the identification of CSNK1G3-dependent nodes that may be exploitable for therapeutic intervention in lymphoma and related hematological malignancies.
This polyclonal knockout cell product is suited for a broad spectrum of research applications. In Wnt signaling pathway analysis, it can be used with TOPFlash luciferase reporter assays to quantify TCF/LEF transcriptional activity or with western blotting for phospho-LRP6 to assess signalosome assembly. Co-immunoprecipitation experiments can evaluate the integrity of Wnt signalosome components such as DVL, AXIN, and GSK3?? in the absence of CSNK1G3. Cell proliferation and viability assays enable the investigation of CSNK1G3??s impact on cell growth and drug responses, particularly in the context of kinase inhibitor screening. For circadian rhythm studies, circadian reporter assays can monitor clock gene oscillations in the knockout background. The CSNK1G3 Knockout Raji Polyclonal Cells thus provide a versatile platform for advanced research in signal transduction, oncology, and chronobiology. For additional details about this product or to request technical support, please contact Ascent Research.
